PNC Financial Services Group
KITE

PNC Financial Services Group’s Kite Pharma, Inc. KITE Stock Holding History

PNC Financial Services Group’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-421
Closed -$76K – 4374
2017
Q3 		$76K Buy
421
+156
+59% +$21.7K ﹤0.01% 2686
2017
Q2 		$27K Sell
265
-335
-56% -$27.3K ﹤0.01% 3208
2017
Q1 		$48K Buy
600
+400
+200% +$24.7K ﹤0.01% 2912
2016
Q4 		$8K Sell
200
-850
-81% -$41.7K ﹤0.01% 3572
2016
Q3 		$58K Buy
1,050
+474
+82% +$26.4K ﹤0.01% 2765
2016
Q2 		$29K Buy
576
+43
+8% +$2.11K ﹤0.01% 3098
2016
Q1 		$24K Sell
533
-144
-21% -$6.97K ﹤0.01% 3206
2015
Q4 		$41K Buy
677
+49
+8% +$3.45K ﹤0.01% 2941
2015
Q3 		$35K Buy
628
+195
+45% +$12.3K ﹤0.01% 3087
2015
Q2 		$26K Sell
433
-3,604
-89% -$206K ﹤0.01% 3391
2015
Q1 		$232K Buy
4,037
+3,900
+2,847% +$261K ﹤0.01% 2121
2014
Q4 		$8K Buy
+137
New +$5.77K ﹤0.01% 3445

PNC Financial Services Group's KITE Position: Q4 2017 in Review

PNC Financial Services Group sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 421 shares — an estimated $76K sold.

PNC Financial Services Group first reported a position in KITE in Q4 2014 and held it in 12 quarters. The position peaked at $232K in Q1 2015. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • PNC Financial Services Group reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • PNC Financial Services Group sold 421 Kite Pharma, Inc. shares in Q4 2017, an estimated $76K.
  • PNC Financial Services Group first reported a position in Kite Pharma, Inc. in Q4 2014 and held it in 12 quarters.
  • PNC Financial Services Group's Kite Pharma, Inc. position peaked at $232K in Q1 2015.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on PNC Financial Services Group's 13F filing for Q4 2017, filed 9 Feb 2018.